Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Schering-Plough has added Omnicom Group’s Merkley + Partners to its roster of agencies, awarding the New York shop creative duties on three non-prescription brands: Miralax laxatives, Chlor-Trimeton allergy medicine and Drixoral cold medicine, the client confirmed.
Billings on the assignments, which came without a review, were not disclosed. This year, through August, Schering had spent more than $20 million in major measured media on Miralax, more than $5 million on Chlor-Trimeton and less than $1 million on Drixoral, according to Nielsen Monitor-Plus.
The
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in